US Broker Ratings

DexCom, Inc. (DXCM) Stock Analysis: Navigating a 17.58% Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM) stands out as a significant player in the healthcare sector, particularly within the medical devices industry. The company, headquartered in San Diego, California, has carved a..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Look at the 34.22% Upside Potential

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable force in the healthcare sector, commanding a market capitalization of $83.23 billion. With its operations rooted in the United States, HCA..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 54% Potential Upside in Biotechnology

In a landscape where biopharmaceutical innovation is as competitive as it is promising, BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out with a market capitalization of $12.98 billion. This Palo Alto-based..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Growth with a 14.87% Potential Upside

For investors eyeing opportunities in the healthcare sector, Teleflex Incorporated (NYSE: TFX) presents an intriguing proposition. With a market capitalization of $5.62 billion, this U.S.-based company is a significant player..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Through the Biotech Maze with a $5.94 Billion Valuation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based biotech firm specializing in Traditional Chinese Medicine (TCM), finds itself at a crucial juncture. With a market capitalization of $5.94 billion,..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 43% Potential Upside

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Birmingham, Alabama, the company has established a robust..

Nuvalent, Inc. (NUVL) Stock Analysis: Investor Outlook and Growth Potential in Biotech

Nuvalent, Inc. (NASDAQ: NUVL), a promising player in the biotechnology sector, is catching the attention of investors, particularly with its potential upside of 3.80% as highlighted by analyst ratings. As..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 39% Potential Upside Amidst Solid Growth

ResMed Inc. (NYSE: RMD) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $27.36 billion, the company..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 35.93% Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, specializes in eye care solutions, offering a comprehensive range of products and services aimed at enhancing vision care worldwide...

AptarGroup, Inc. (ATR) Stock Analysis: Unveiling a 33% Potential Upside

AptarGroup, Inc. (NYSE: ATR) stands out as a compelling investment opportunity within the healthcare sector, specifically in the medical instruments and supplies industry. As a leader in designing and manufacturing..

Repligen Corporation (RGEN) Stock Analysis: Assessing a 33% Upside Potential in Bioprocessing Innovation

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the Medical Instruments & Supplies industry. With a market capitalization of $7.45 billion, Repligen is a significant player,..

CVS Health Corporation (CVS) Stock Analysis: Strong Buy Ratings and 6.79% Upside Potential

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, with a robust market capitalization of $125.45 billion. As the healthcare industry continues to evolve, CVS’s..

Quest Diagnostics Incorporated (DGX)

⚠️ No article content returned.

..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 22% Potential Upside in the Biotechnology Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out as a compelling investment opportunity in the biotechnology sector, with a notable potential upside of 22.39% based on analysts’ average target price of..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 28.97% Potential Upside in the Healthcare Sector

Thermo Fisher Scientific Inc (NYSE: TMO) stands out as a key player in the healthcare sector, offering a diversified portfolio that spans life sciences solutions, analytical instruments, specialty diagnostics, and..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 29.92% Potential Upside in the Healthcare Sector

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Tel Aviv-Yafo, Israel, Teva..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth in Genomic Innovation with a 4.8% Revenue Surge

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. Known for its cutting-edge sequencing and array-based solutions, Illumina is..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 14.91% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD), a beacon in the biotechnology sector, has captured investor attention with its robust pipeline targeting RAS-addicted cancers. With a market capitalization of $34.65 billion, this..

AstraZeneca PLC (AZN) Stock Analysis: Robust Growth and Analyst Confidence Propel a 28% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a stalwart in the healthcare sector, is drawing significant investor interest with its impressive market cap of $271.29 billion and a promising potential upside of 28.33%...

BioNTech SE (BNTX) Stock Analysis: Key Insights on Growth Potential and Market Position

BioNTech SE (NASDAQ: BNTX) has been a prominent name in the biotechnology sector, particularly recognized for its pioneering work in mRNA technology, which came to global attention with the development..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds